menu
    • menu

    Company profile for Cognito Therapeutics

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cognito is a clinical-stage company developing novel, digital therapeutics with its proprietary neuromodulation platform which holds the promise for disease-modification in neurodegenerative diseases such as Alzheimer’s.Our mission is to develop breakthrough therapies that improve the lives of our patients and their care partners. There may be opportunities to help Cognito in its development by participating in surveys, int...
    Cognito is a clinical-stage company developing novel, digital therapeutics with its proprietary neuromodulation platform which holds the promise for disease-modification in neurodegenerative diseases such as Alzheimer’s.Our mission is to develop breakthrough therapies that improve the lives of our patients and their care partners. There may be opportunities to help Cognito in its development by participating in surveys, interviews, and other product research activities. These activities will help us develop products that best meet the needs of our patients and their care partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cognito TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1218 Massachusetts Ave, Suite 200 Cambridge, MA 02138
    Telephone
    Telephone
    857-201-5088
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cognitotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cognito-therapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cognito Therapeutics Presents New Data on Spectris in AD at AD/PD
    Cognito Therapeutics Presents New Data on Spectris in AD at AD/PD

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317276762/en/Cognito-Therapeutics-Presents-New-Data-on-Spectris-in-Alzheimers-Disease-at-ADPD-2026

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    Cognito Pharma Appoints Fagan As EVP For Alzheimer's Portfolio
    Cognito Pharma Appoints Fagan As EVP For Alzheimer's Portfolio

    11 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-11/cognito-therapeutics-appoints-thomas-fagan-as-executive-vice-president-alzheimer-s-portfolio

    PHARMIWEB
    11 Mar 2026
    Share Share
    Cognito Therapeutics Announces Oversubscribed $105 Million
    Cognito Therapeutics Announces Oversubscribed $105 Million

    05 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260305121811/en/Cognito-Therapeutics-Announces-Oversubscribed-%24105-Million-Series-C-Financing-to-Advance-Spectris-in-Alzheimers-Disease

    BUSINESSWIRE
    05 Mar 2026
    Share Share
    Cognito Therapeutics Unveil Spectris Biomarker Data in AD at CTAD
    Cognito Therapeutics Unveil Spectris Biomarker Data in AD at CTAD

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203036894/en/Cognito-Therapeutics-Announces-Presentation-of-New-CSF-Proteomic-and-EEG-Biomarker-Data-for-Spectris-in-Alzheimers-Disease-at-CTAD-2025

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    Cognito Therapeutics Unveils Spectris Biomarker Data at CTAD 2025
    Cognito Therapeutics Unveils Spectris Biomarker Data at CTAD 2025

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118173236/en/Cognito-Therapeutics-to-Present-New-Biomarker-Data-for-Spectris-in-Alzheimers-Disease-at-CTAD-2025

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    WVU Rockefeller Neuroscience Institute, Cognito Therapeutics
    WVU Rockefeller Neuroscience Institute, Cognito Therapeutics

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113711270/en/WVU-Rockefeller-Neuroscience-Institute-and-Cognito-Therapeutics-Launch-Brain-Health-Collaboratory-to-Accelerate-Neurotherapies-with-AI-powered-Research

    BUSINESSWIRE
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search